EXPRESSION OF THE MDR1 P-GLYCOPROTEIN GENE - A MECHANISM OF ESCAPE FROM GLUCOCORTICOID-INDUCED APOPTOSIS

被引:46
作者
GRUOL, DJ
BOURGEOIS, S
机构
[1] Regulatory Biology Laboratory, Salk Institute for Biological Studies, San Diego, 92186-5800, CA
来源
BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE | 1994年 / 72卷 / 11-12期
关键词
MULTIDRUG RESISTANCE; GLUCOCORTICOIDS; APOPTOSIS; LYMPHOMAS; RU486;
D O I
10.1139/o94-075
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Glucocorticoid hormones cause apoptosis in the murine T-lymphoma cell line WEHI-7. Glucocorticoid receptors in these cells are cytoplasmic proteins that translocate to the nucleus upon binding hormone. Thus, regulation of cytoplasmic glucocorticoid concentrations controls the level of activated receptors and sensitivity to steroid-induced apoptosis. We found that expression of the mdr1 P-glycoprotein gene produces a reduced accumulation of dexamethasone in WEHI-7 cells. Concomitantly, there is a suppression of dexamethasone-induced changes in transcription and a decrease in steroid sensitivity. P-glycoproteins are known to cause an outward, ATP-dependent transport of a variety of unrelated hydrophobic drugs across the plasma membrane. Our results indicate that glucocorticoid transport by P-glycoproteins depends upon the presence of an hydroxyl group at position 11 of corticosteroids and is enhanced by hydroxyl groups at the positions 16, 17, and 21. The antiprogestin RU486, which contains a dimethyl aminophenyl substitution at the position 11, is not transported by the mdr1 P-glycoprotein. We have found that RU486 is an inhibitor of P-glycoprotein function, indicating that steroid analogs could be useful chemosensitizers in patients undergoing chemotherapy.
引用
收藏
页码:561 / 571
页数:11
相关论文
共 60 条
[1]   TREATMENT OF BREAST-CANCER WITH DIFFERENT ANTIPROGESTINS - PRECLINICAL AND CLINICAL-STUDIES [J].
BAKKER, GH ;
SETYONOHAN, B ;
PORTENGEN, H ;
DEJONG, FH ;
FOEKENS, JA ;
KLIJN, JGM .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1990, 37 (06) :789-794
[2]   GENES NEWLY IDENTIFIED AS REGULATED BY GLUCOCORTICOIDS IN MURINE THYMOCYTES [J].
BAUGHMAN, G ;
HARRIGAN, MT ;
CAMPBELL, NF ;
NURRISH, SJ ;
BOURGEOIS, S .
MOLECULAR ENDOCRINOLOGY, 1991, 5 (05) :637-644
[3]   CONTRAGESTION AND OTHER CLINICAL-APPLICATIONS OF RU-486, AN ANTIPROGESTERONE AT THE RECEPTOR [J].
BAULIEU, EE .
SCIENCE, 1989, 245 (4924) :1351-1357
[4]   PLEIOTROPIC PHENOTYPE OF COLCHICINE-RESISTANT CHO CELLS - CROSS-RESISTANCE AND COLLATERAL SENSITIVITY [J].
BECHHANSEN, NT ;
TILL, JE ;
LING, V .
JOURNAL OF CELLULAR PHYSIOLOGY, 1976, 88 (01) :23-31
[5]   DNA-BINDING PROPERTIES OF GLUCOCORTICOSTEROID RECEPTORS BOUND TO THE STEROID ANTAGONIST RU-486 [J].
BOURGEOIS, S ;
PFAHL, M ;
BAULIEU, EE .
EMBO JOURNAL, 1984, 3 (04) :751-755
[6]  
BOURGEOIS S, 1978, CANCER RES, V38, P4279
[7]   EXPRESSION OF AN MDR GENE IS ASSOCIATED WITH A NEW FORM OF RESISTANCE TO DEXAMETHASONE-INDUCED APOPTOSIS [J].
BOURGEOIS, S ;
GRUOL, DJ ;
NEWBY, RF ;
RAJAH, FM .
MOLECULAR ENDOCRINOLOGY, 1993, 7 (07) :840-851
[8]   DIPLOID AND HAPLOID STATES OF GLUCOCORTICOID RECEPTOR GENE OF MOUSE LYMPHOID-CELL LINES [J].
BOURGEOIS, S ;
NEWBY, RF .
CELL, 1977, 11 (02) :423-430
[9]  
BOURGEOIS S, 1979, CANCER RES, V39, P4749
[10]  
BOURGEOIS S, 1985, BIOCHEM ACTION HORM, P311